Diagnostic accuracy of the droplet digital PCR POLE mutation test in endometrial cancer: comparison with Sanger sequencing and NGS
Journal of Gynecologic Oncology · 2026 · 37 (4)
DOI: 10.3802/jgo.2026.37.e83 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Yung-Taek Ouh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, Korea University Ansan Hospital, Ansan, Korea. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Polymerase Chain Reaction, High-Throughput Nucleotide Sequencing, DNA Polymerase II. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
OBJECTIVE: To evaluate the diagnostic accuracy of droplet digital polymerase chain reaction (ddPCR) for detecting polymerase epsilon (POLE) mutations in endometrial cancer (EC), comparing it with traditional Sanger sequencing and next-generation sequencing (NGS). METHODS: Tumor DNA from 132 patients with EC was analyzed initially using both ddPCR and Sanger sequencing. Discordant cases (n=20) underwent further analysis using NGS as the reference standard. This study compared the sensitivity, specificity, and overall concordance of ddPCR against Sanger sequencing results, validated by NGS. RESULTS: Among the 20 discrepant samples, ddPCR detected POLE mutations in 15 cases (75%). All ddPCR results matched exactly with NGS findings, including the detection of 11 low-frequency mutations missed by Sanger sequencing. ddPCR also corrected 2 false-positive results initially identified by Sanger sequencing. No false negatives were detected by ddPCR. CONCLUSION: ddPCR demonstrated superior sensitivity and specificity in detecting POLE mutations compared to Sanger sequencing and showed perfect agreement with NGS. With its rapid turnaround, simplicity, and cost-effectiveness, ddPCR is highly suitable for routine clinical use, potentially enhancing patient management and outcomes in EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, Korea University Ansan Hospital, Ansan, Korea.
- Department of Obstetrics & Gynecology, Korea University Guro Hospital, Seoul, Korea.
- Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
- Department of Obstetrics & Gynecology, Korea University Guro Hospital, Seoul, Korea. jhhong93@korea.ac.kr.
ORCID-Profile: Yung-Taek Ouh, Hyun-Woong Cho, Kyung-Jin Min, Jae-Kwan Lee, Yikyeong Chun, Jin Hwa Hong
Zitieren
APA
Ouh, Y. T., Cho, H. W., Min, K. J., Lee, J. K., Chun, Y., & Hong, J. H. (2026). Diagnostic accuracy of the droplet digital PCR POLE mutation test in endometrial cancer: comparison with Sanger sequencing and NGS. Journal of Gynecologic Oncology, 37(4). https://doi.org/10.3802/jgo.2026.37.e83
Vancouver
Ouh YT, Cho HW, Min KJ, Lee JK, Chun Y, Hong JH. Diagnostic accuracy of the droplet digital PCR POLE mutation test in endometrial cancer: comparison with Sanger sequencing and NGS. Journal of Gynecologic Oncology. 2026;37(4). doi:10.3802/jgo.2026.37.e83
BibTeX
@article{Ouh2026,
author = {Ouh, Yung-Taek and Cho, Hyun-Woong and Min, Kyung-Jin and Lee, Jae-Kwan and Chun, Yikyeong and Hong, Jin Hwa},
title = {Diagnostic accuracy of the droplet digital PCR POLE mutation test in endometrial cancer: comparison with Sanger sequencing and NGS},
journal = {Journal of Gynecologic Oncology},
year = {2026},
volume = {37},
number = {4},
doi = {10.3802/jgo.2026.37.e83}
}
EUVIMED